![\"Percutaneous](\"https:\/\/rtmedical.com.br\/wp-content\/uploads\/2026\/03\/ablacao-renal-vs-cirurgia-cancer-rim.jpg\")
Small renal masses \u2014 generally defined as tumors smaller than 4 cm (stage T1a) \u2014 represent a growing proportion of kidney cancer diagnoses, largely due to increased use of imaging studies such as CT and ultrasound for other indications. Many of these tumors are discovered incidentally, raising questions about the optimal therapeutic approach, a topic connected to AI’s role in managing incidental radiological findings<\/a>.<\/p>\n The main ablation modalities used for renal tumors include cryoablation and radiofrequency ablation (RFA), with microwave ablation (MWA) gaining ground more recently. Each technique offers specific advantages.<\/p>\n Cryoablation uses argon gas to create an ice ball that destroys tumor tissue through freezing. The ablation zone can be visualized in real time via CT or MRI, enabling precise monitoring during the procedure. Radiofrequency generates heat through alternating current, while microwaves produce higher temperatures in less time.<\/p>\n All these techniques share a fundamental advantage: they are performed percutaneously, guided by imaging (typically CT), without the need for significant surgical incision. Patients are typically discharged the same day or the following day, compared to the 2\u20134 day hospitalization associated with laparoscopic or robotic partial nephrectomy.<\/p>\n Beyond comparable oncologic efficacy, percutaneous ablation offers several practical advantages. Renal function preservation is among the most relevant: because ablation destroys less healthy renal parenchyma than surgery, patients with a solitary kidney, borderline renal function, or comorbidities contraindicating general anesthesia are particularly suitable candidates.<\/p>\n The complication profile is also generally more favorable. The most common ablation complications \u2014 self-limiting perirenal hematoma and transient pain \u2014 are typically less severe than potential surgical complications such as significant bleeding, urinary fistula, or injury to adjacent organs.<\/p>\n For centers investing in interventional radiology, these results reinforce the importance of developing structured renal ablation programs. The learning curve exists, but the combination of precise image guidance and modern ablation technology makes the procedure accessible to interventional radiologists with adequate training.<\/p>\n In Brazil, percutaneous renal ablation is still less commonly used than in North American and European centers, although leading hospitals such as Hospital das Cl\u00ednicas da USP, Hospital S\u00edrio-Liban\u00eas, and Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo (ICESP) already perform the procedure regularly. The main barrier is not technical but rather one of adoption: many urologists and patients still do not consider ablation as a first-line option.<\/p>\n Studies like this one, published in high-impact journals, contribute to changing that perception. For Brazilian radiology, they represent an opportunity to expand the specialty’s scope of practice in oncology. The trend toward convergence between robotics and thermal ablation, exemplified by the recent NeuWave acquisition by Quantum Surgical<\/a>, suggests these technologies will continue evolving in precision and accessibility.<\/p>\n Continued advances in ablation techniques, combined with increasingly precise image guidance and AI’s potential for treatment planning, suggest percutaneous ablation will continue gaining ground as the treatment of choice for small renal tumors. Long-term prospective studies will be essential for consolidating this evidence and eventually updating clinical practice guidelines.<\/p>\nAvailable Ablation Techniques<\/h2>\n
Advantages of the Minimally Invasive Approach<\/h2>\n
Context and Implications for Brazil<\/h2>\n
Future Outlook<\/h2>\n